Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 1;63(5):657-62.
doi: 10.1093/cid/ciw333. Epub 2016 May 20.

Vaccines for Healthcare-associated Infections: Promise and Challenge

Jane M Knisely  1 , Baoying Liu  1 , Ryan T Ranallo  1 , Lanling Zou  1
Affiliations

Vaccines for Healthcare-associated Infections: Promise and Challenge

Jane M Knisely et al. Clin Infect Dis. .

Abstract

As antibiotic resistance increases and the rate of antibiotic development slows, it is becoming more urgent to develop novel approaches to prevent and mitigate serious bacterial and fungal infections. Healthcare-associated infections (HAIs), including those caused by Clostridium difficile, Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, carbapenem-resistant Enterobacteriaceae, and Candida species, are a major cause of morbidity, mortality, and healthcare costs. HAIs are also a key driver of antibiotic use. Vaccines directed toward these pathogens could help prevent a large number of HAIs and associated antibiotic use if administered to targeted populations. Despite numerous scientific and operational challenges, there are vaccine candidates in late-stage clinical development for C. difficile, S. aureus, and P. aeruginosa Basic, preclinical, and early clinical research to develop vaccines for other types of HAIs is also under way. In addition, other prophylactic immune interventions, such as monoclonal antibodies, for several of these pathogens are in advanced development. Here we describe the promise, challenges, and current pipeline of vaccines to prevent HAIs.

Keywords: Clostridium difficile; Staphylococcus aureus; antibiotic resistance; healthcare-associated infections; vaccines.

PubMed Disclaimer

References

    1. Magill SS, Edwards JR, Beldavs ZG et al. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA 2014; 312:1438–46. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Antibiotic resistant threats in the United States, 2013. Available at: www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed 1 March 2016.
    1. Lessa FC, Mu Y, Bamberg WM et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372:825–34. - PMC - PubMed
    1. The White House. National strategy for combating antibiotic-resistant bacteria, 2014. Available at: https://www.whitehouse.gov/sites/default/files/docs/carb_national_strate.... Accessed 1 March 2016.
    1. The White House. National action plan for combating antibiotic-resistant bacteria, 2015. Available at: https://www.whitehouse.gov/sites/default/files/docs/national_action_plan.... Accessed 1 March 2016.

MeSH terms

Substances